Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial Cyclin-dependent kinase (CDK) 4/6 inhibitors (CDK4 ...
The tibremciclib trial demonstrated a significant PFS benefit and high objective response rates in a single-country cohort without prior CDK4/6 inhibitor exposure. Overall survival (OS) data remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results